111 (YI) Director Chen Yang Luke Sells $850 of Stock
Insider Chen Yang Luke sold 3,400 shares of 111, Inc. on May 27, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Chen Yang Luke, Director at 111, Inc. ($YI), sold 3,400 shares at an average price of $0.25, worth about $850, on May 27, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $YI is down 2.6% after 1 week, down 24.4% after 1 month and down 42.0% to date (from the $5.40 close on May 27, 2026).
Key Points
- On May 27, 2026, Chen Yang Luke sold 3,400 shares of 111, Inc. for $850, at a price of $0.25 per share.
- 111, Inc. is currently trading at $4.57, significantly above its 52-week low of $2.48.
- Chen Yang Luke's total holdings after this sale stand at 126,295 shares, following his recent purchases.
Get $YI trade alerts by text
We text you when insiders, Congress or big funds trade $YI. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated 111, Inc. alert may contain errors. Disclosures
Insider Buying and Selling at 111, Inc.
On May 27, 2026, Chen Yang Luke sold 3,400 shares of 111, Inc. (NasdaqGM: YI) for a total of $850. The shares were sold at a price of $0.25 each. This sale comes as part of his ongoing activity with the company's stock, where he has previously increased his stake significantly.
Recent Insider Activity
Chen Yang Luke has been active with his holdings in 111, Inc. In recent months, he acquired 126,295 shares on September 8, 2023, and made additional purchases of 54,759 shares on May 11, 2026, followed by another acquisition of 413,168 shares on May 12, 2026. These trades suggest a strong commitment to his position in the company.
How 111, Inc. Stock Has Traded
Currently, 111, Inc. is trading at $4.57, which is well above its 52-week low of $2.48. The stock has seen fluctuations, with a high of $11.17 in the past year. This recent sale by Chen Yang Luke occurs while the stock is positioned above its 200-day moving average of $5.09, indicating some resilience in its price action amidst the market.
What 111, Inc. Does
111, Inc. operates an integrated healthcare platform in China, offering a range of services from pharmaceutical distribution to online consultations. The company's growth and operations are crucial as it navigates the evolving healthcare landscape in the region.
What's Ahead for 111, Inc.
Investors will be watching for 111, Inc.'s upcoming earnings report scheduled for March 19, 2026. It's important to note that the recent insider trades reflect past decisions and may not indicate current or future strategies. As always, the trades reported under the STOCK Act provide a snapshot of insider activities that can inform market sentiment.
Source: Chen Yang Luke's Form 4 filing on $YI (May 27, 2026). Find the original filing: YI Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts
